Eli Lilly and Company (Lilly) owns and operates a pharmaceutical manufacturing plant at 1650 Lilly Road, Lafayette, Indiana (referred to as Tippecanoe Laboratories). In a Finding of Violation issued March 25, 2008, the U.S. Environmental Protection Agency finds that Lilly violated Section 112 of the Clean Air Act, 42 U.S.C. § 7412, and the National Emission Standards for Organic Hazardous Air Pollutants for Equipment Leaks at 40 C.F.R. Part 63, Subpart H. Specifically, Lilly failed to conduct a sufficient first attempt at repair of a leaking component. EPA discovered this violation through an inspection it conducted on September 10-12, 2007 inspection.
EPA is issuing the Administrative Penalty Order concurrently with this Consent Agreement and Final Order (CAFO). Lilly demonstrated compliance by eventually making an attempt to repair the leaking component 3 days after the last date it was allowed. Under this CAFO, Lilly will pay a penalty of $12,000.